KAUST, AEON Collective, and KAPSARC released a report during MENA Climate Week assessing climate change impacts in Saudi Arabia under a 3°C warming scenario. The report finds that Saudi Arabia is experiencing climate change at an accelerated pace, with potential temperature increases of up to 5.6°C by the end of the century. It highlights the need for policy choices and adaptation strategies to mitigate impacts on ecosystems, urban environments, and human health. Why it matters: This comprehensive analysis provides critical insights for Saudi Arabia to inform its climate policies and adaptation efforts, addressing challenges like coral bleaching, desert expansion, and increased health risks.
KAUST researchers, in collaboration with the Salk Institute and Altos Labs, have identified a class of RNA (LINE-1) that, when compromised, leads to accelerated aging, as seen in progeria. They devised an antisense RNA strategy to block the aberrant function of L1 RNA, reversing the disease in mice and patient-derived cells. Published in Science Translational Medicine, the research suggests that targeting LINE-1 RNA could treat progeroid syndromes and other age-related diseases. Why it matters: This RNA-based approach provides a potential therapeutic avenue for treating premature aging diseases and extending human health span in the region and globally.
KAUST Professor Raquel Peixoto will co-lead the first global body under the International Union for Conservation of Nature (IUCN) to safeguard microbial biodiversity. The Microbial Conservation Specialist Group will explore ecological disruption and potential extinction of microbes vital to ecosystems and human health. The group will assess extinction risks, set conservation priorities, and establish criteria for a microorganism Red List. Why it matters: This initiative highlights the growing recognition of the importance of microbial ecosystems and positions KAUST as a leader in integrating microbiology into global biodiversity governance.
KAUST researchers are investigating the sources and chemistry of airborne particles to tackle urban air pollution. The research integrates laboratory simulations of atmospheric reactions with field measurements to understand the formation mechanisms of particulate matter (PM). They are also developing cellular and animal models to test how different air pollutants affect human health, in collaboration with the Center of Excellence for Smart Health. Why it matters: This research can inform targeted control strategies to manage emissions and improve air quality in Saudi Arabia and other countries facing similar pollution challenges.
KAUST alumnus Yu Li was named in Forbes' 30 Under 30 Asia List for his work developing algorithms to solve problems in biology and healthcare. Li, now an assistant professor at CUHK, was recognized for his computational tools to identify antibiotic-resistant genes. His research focuses on computational biology, human health, biomolecular structure prediction, and AI-driven drug discovery. Why it matters: This recognition highlights the impact of KAUST's programs in fostering AI talent in the region, particularly in the growing field of bioinformatics and healthcare.
KAUST researchers studied microplastic distribution in the open ocean during a recent expedition. They found microplastics everywhere but in 100 times lower quantities than expected based on production estimates. The study found larger plastic debris at expected levels, but smaller microplastics were disappearing, suggesting they are either sinking or entering the marine food chain. Why it matters: This research highlights the urgent need to understand the fate of microplastics in marine ecosystems and their potential impact on marine life and human health.
Dr. Farida Al Hosani, a UAE public health leader and MBZUAI Executive Program graduate, has been at the forefront of the nation’s public health strategy, specializing in infectious diseases. She emphasizes the growing importance of AI in healthcare, particularly in areas like early detection, drug discovery, and public health strategies. Al Hosani has worked on several AI initiatives, including building algorithms and predictive modeling systems to bridge gaps in human health, especially in prevention. Why it matters: This highlights the increasing role of AI in transforming healthcare in the UAE, with public health leaders leveraging AI tools to improve disease prevention and treatment.
A talk discusses the challenges of single-cell data analysis, such as feature sparsity and the effects of rare cells. AI/ML strategies are uniquely positioned to model this data. ImYoo, a startup founded in 2021, is applying single-cell model architectures for unsupervised discovery of patient groupings and predicting sample-level phenotypical data in autoimmune disease. Why it matters: This highlights the growing application of AI/ML in analyzing single-cell data for population-scale human health studies, an area ripe for innovation and improvement in the Middle East's growing biotech sector.